These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 946314)

  • 21. [Swine insulin and its advantages in the therapy of diabetes mellitus].
    Tirkina TN; Kliachko VR
    Probl Endokrinol (Mosk); 1974; 20(1):20-4. PubMed ID: 4849838
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of using single-component insulin preparations in diabetes mellitus and generalized lipodystrophy].
    Gorelysheva VA; Zhdanova ES; Lobanova AM; Arbuzova MI
    Probl Endokrinol (Mosk); 1990; 36(2):52-5. PubMed ID: 2194203
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membranous lipodystrophy associated with insulin lipoatrophy.
    Kim KT; Ahn SK; Choi EH; Lee SH
    Int J Dermatol; 1997 Apr; 36(4):299-301. PubMed ID: 9169335
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.
    Chantelau EA; Prätor R; Prätor J
    J Med Case Rep; 2014 Jun; 8():223. PubMed ID: 24961832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine.
    Cook IF
    Hum Vaccin Immunother; 2022 Nov; 18(5):2042136. PubMed ID: 35258436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human insulin analog--induced lipoatrophy.
    Lopez X; Castells M; Ricker A; Velazquez EF; Mun E; Goldfine AB
    Diabetes Care; 2008 Mar; 31(3):442-4. PubMed ID: 18162498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local and general non-immunologic complications of insulin therapy].
    Scapellato L
    Recenti Prog Med; 1973 Dec; 55(6):503-26. PubMed ID: 4592315
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of lipoatrophy with human insulin-therapy.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].
    Dziura M; Wasikowa R
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):61-3. PubMed ID: 18577350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mono component insulin and its use in insulin induced lipoatrophy.
    J Pak Med Assoc; 1976 Dec; 26(11):233. PubMed ID: 829356
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
    Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
    Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in the sensitivity of lipoatrophic tissues to insulin under the effects of novocaine].
    Talantov VV; Iaroshevskiĭ IuA
    Probl Endokrinol (Mosk); 1975; 21(3):14-6. PubMed ID: 1144316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoatrophy at insulin injection site.
    Velayutham P; Shriraam M; Bhadada S; Bhansali A
    J Assoc Physicians India; 2008 May; 56():335. PubMed ID: 18700641
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.
    Atmaca A; Erbas T
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):340-3. PubMed ID: 15977102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.